Evaluation of Short-to-medium Term Efficacy of Guselkumab and Secukinumab in Overweight and Obese Patients with Moderate to Severe Plaque Psoriasis: A 24-Week Single-center Retrospective Study

Background: Overweight and obesity are common in patients with psoriasis and are associated with increased disease severity and declined treatment response. Aims: To evaluate the short-to-medium term (24w) efficacy and safety of two biologics, including Guselkumab and Secukinumab, in overweight and...

Full description

Bibliographic Details

Main Authors:	Xiuqiu Lin, Min Ou, Yang Li, Junjie Lin, Yunling Yan, Xiaohua Wang
Format:	Artigo
Language:	Inglês
Published:	Wolters Kluwer Medknow Publications 2025-09-01
Series:	Indian Journal of Dermatology
Subjects:	body mass index guselkumab moderate-to-severe plaque psoriasis overweight and obesity secukinumab
Online Access:	https://journals.lww.com/10.4103/ijd.ijd_663_23
Tags:	Add Tag No Tags, Be the first to tag this record!